HEADER APOPTOSIS 31-MAY-03 1OHU TITLE STRUCTURE OF CAENORHABDITIS ELEGANS CED-9 COMPND MOL_ID: 1; COMPND 2 MOLECULE: APOPTOSIS REGULATOR CED-9; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CED-9, CELL DEATH PROTEIN 9; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CAENORHABDITIS ELEGANS; SOURCE 3 ORGANISM_TAXID: 6239; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS APOPTOSIS, CED-9, BCL-2 FAMILY EXPDTA X-RAY DIFFRACTION AUTHOR J.-S.JEONG,N.-C.HA,B.-H.OH REVDAT 3 24-FEB-09 1OHU 1 VERSN REVDAT 2 12-JUL-05 1OHU 1 JRNL REVDAT 1 14-AUG-03 1OHU 0 JRNL AUTH J.-S.WOO,J.-S.JUNG,N.-C.HA,J.SHIN,K.-H.KIM,W.LEE, JRNL AUTH 2 B.-H.OH JRNL TITL UNIQUE STRUCTURAL FEATURES OF A BCL-2 FAMILY JRNL TITL 2 PROTEIN CED-9 AND BIOPHYSICAL CHARACTERIZATION OF JRNL TITL 3 CED-9/EGL-1 INTERACTIONS JRNL REF CELL DEATH DIFFER. V. 10 1310 2003 JRNL REFN ISSN 1350-9047 JRNL PMID 12894216 JRNL DOI 10.1038/SJ.CDD.4401303 REMARK 2 REMARK 2 RESOLUTION. 2.03 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.03 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.0 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 84.1 REMARK 3 NUMBER OF REFLECTIONS : 21636 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.0 REMARK 3 FREE R VALUE TEST SET COUNT : 1055 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2513 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 144 REMARK 3 SOLVENT ATOMS : 61 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.089 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1OHU COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-JUN-03. REMARK 100 THE PDBE ID CODE IS EBI-12821. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PAL/PLS REMARK 200 BEAMLINE : 6B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97921 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21636 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.030 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 84.1 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : 0.04200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.4 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.7 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% PEG 8K ,0.1M HEPES PH7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 46.02500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED MUTATIONS: CHAINS A, B CYS107SER, CYS135SER, REMARK 400 CYS164SER REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 68 REMARK 465 LYS A 69 REMARK 465 ILE A 70 REMARK 465 ALA A 159 REMARK 465 GLN A 160 REMARK 465 THR A 161 REMARK 465 ASP A 162 REMARK 465 GLN A 163 REMARK 465 SER A 164 REMARK 465 GLY B 68 REMARK 465 LYS B 69 REMARK 465 ILE B 70 REMARK 465 ASN B 71 REMARK 465 ASP B 72 REMARK 465 TRP B 73 REMARK 465 GLU B 74 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 71 CG OD1 ND2 REMARK 470 ARG A 143 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 211 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 212 CG OD1 ND2 REMARK 470 LYS A 215 CG CD CE NZ REMARK 470 GLU A 216 CG CD OE1 OE2 REMARK 470 HIS A 217 CG ND1 CD2 CE1 NE2 REMARK 470 ASN A 218 CG OD1 ND2 REMARK 470 LYS A 229 CG CD CE NZ REMARK 470 ARG A 237 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 241 CG CD OE1 OE2 REMARK 470 LYS A 242 CA C O CB CG CD CE NZ REMARK 470 GLU B 75 CG CD OE1 OE2 REMARK 470 GLU B 190 CG CD OE1 OE2 REMARK 470 LYS B 215 CG CD CE NZ REMARK 470 GLU B 216 CG CD OE1 OE2 REMARK 470 ASN B 218 CG OD1 ND2 REMARK 470 ARG B 237 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 242 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU B 129 CD GLU B 129 OE2 0.079 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG B 154 -8.09 -59.30 REMARK 500 THR B 155 51.05 -149.83 REMARK 500 GLN B 163 35.58 -71.17 REMARK 500 PRO B 165 -141.29 -73.08 REMARK 500 GLU B 187 31.46 -89.48 REMARK 500 ASN B 212 -54.58 -124.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): DBREF 1OHU A 68 242 UNP P41958 CED9_CAEEL 68 242 DBREF 1OHU B 68 242 UNP P41958 CED9_CAEEL 68 242 SEQADV 1OHU SER A 107 UNP P41958 CYS 107 ENGINEERED SEQADV 1OHU SER A 135 UNP P41958 CYS 135 ENGINEERED SEQADV 1OHU SER A 164 UNP P41958 CYS 164 ENGINEERED SEQADV 1OHU SER B 107 UNP P41958 CYS 107 ENGINEERED SEQADV 1OHU SER B 135 UNP P41958 CYS 135 ENGINEERED SEQADV 1OHU SER B 164 UNP P41958 CYS 164 ENGINEERED SEQRES 1 A 175 GLY LYS ILE ASN ASP TRP GLU GLU PRO ARG LEU ASP ILE SEQRES 2 A 175 GLU GLY PHE VAL VAL ASP TYR PHE THR HIS ARG ILE ARG SEQRES 3 A 175 GLN ASN GLY MSE GLU TRP PHE GLY ALA PRO GLY LEU PRO SEQRES 4 A 175 SER GLY VAL GLN PRO GLU HIS GLU MSE MSE ARG VAL MSE SEQRES 5 A 175 GLY THR ILE PHE GLU LYS LYS HIS ALA GLU ASN PHE GLU SEQRES 6 A 175 THR PHE SER GLU GLN LEU LEU ALA VAL PRO ARG ILE SER SEQRES 7 A 175 PHE SER LEU TYR GLN ASP VAL VAL ARG THR VAL GLY ASN SEQRES 8 A 175 ALA GLN THR ASP GLN SER PRO MSE SER TYR GLY ARG LEU SEQRES 9 A 175 ILE GLY LEU ILE SER PHE GLY GLY PHE VAL ALA ALA LYS SEQRES 10 A 175 MSE MSE GLU SER VAL GLU LEU GLN GLY GLN VAL ARG ASN SEQRES 11 A 175 LEU PHE VAL TYR THR SER LEU PHE ILE LYS THR ARG ILE SEQRES 12 A 175 ARG ASN ASN TRP LYS GLU HIS ASN ARG SER TRP ASP ASP SEQRES 13 A 175 PHE MSE THR LEU GLY LYS GLN MSE LYS GLU ASP TYR GLU SEQRES 14 A 175 ARG ALA GLU ALA GLU LYS SEQRES 1 B 175 GLY LYS ILE ASN ASP TRP GLU GLU PRO ARG LEU ASP ILE SEQRES 2 B 175 GLU GLY PHE VAL VAL ASP TYR PHE THR HIS ARG ILE ARG SEQRES 3 B 175 GLN ASN GLY MSE GLU TRP PHE GLY ALA PRO GLY LEU PRO SEQRES 4 B 175 SER GLY VAL GLN PRO GLU HIS GLU MSE MSE ARG VAL MSE SEQRES 5 B 175 GLY THR ILE PHE GLU LYS LYS HIS ALA GLU ASN PHE GLU SEQRES 6 B 175 THR PHE SER GLU GLN LEU LEU ALA VAL PRO ARG ILE SER SEQRES 7 B 175 PHE SER LEU TYR GLN ASP VAL VAL ARG THR VAL GLY ASN SEQRES 8 B 175 ALA GLN THR ASP GLN SER PRO MSE SER TYR GLY ARG LEU SEQRES 9 B 175 ILE GLY LEU ILE SER PHE GLY GLY PHE VAL ALA ALA LYS SEQRES 10 B 175 MSE MSE GLU SER VAL GLU LEU GLN GLY GLN VAL ARG ASN SEQRES 11 B 175 LEU PHE VAL TYR THR SER LEU PHE ILE LYS THR ARG ILE SEQRES 12 B 175 ARG ASN ASN TRP LYS GLU HIS ASN ARG SER TRP ASP ASP SEQRES 13 B 175 PHE MSE THR LEU GLY LYS GLN MSE LYS GLU ASP TYR GLU SEQRES 14 B 175 ARG ALA GLU ALA GLU LYS MODRES 1OHU MSE A 97 MET SELENOMETHIONINE MODRES 1OHU MSE A 115 MET SELENOMETHIONINE MODRES 1OHU MSE A 116 MET SELENOMETHIONINE MODRES 1OHU MSE A 119 MET SELENOMETHIONINE MODRES 1OHU MSE A 166 MET SELENOMETHIONINE MODRES 1OHU MSE A 185 MET SELENOMETHIONINE MODRES 1OHU MSE A 186 MET SELENOMETHIONINE MODRES 1OHU MSE A 225 MET SELENOMETHIONINE MODRES 1OHU MSE A 231 MET SELENOMETHIONINE MODRES 1OHU MSE B 97 MET SELENOMETHIONINE MODRES 1OHU MSE B 115 MET SELENOMETHIONINE MODRES 1OHU MSE B 116 MET SELENOMETHIONINE MODRES 1OHU MSE B 119 MET SELENOMETHIONINE MODRES 1OHU MSE B 166 MET SELENOMETHIONINE MODRES 1OHU MSE B 185 MET SELENOMETHIONINE MODRES 1OHU MSE B 186 MET SELENOMETHIONINE MODRES 1OHU MSE B 225 MET SELENOMETHIONINE MODRES 1OHU MSE B 231 MET SELENOMETHIONINE HET MSE A 97 8 HET MSE A 115 8 HET MSE A 116 8 HET MSE A 119 8 HET MSE A 166 8 HET MSE A 185 8 HET MSE A 186 8 HET MSE A 225 8 HET MSE A 231 8 HET MSE B 97 8 HET MSE B 115 8 HET MSE B 116 8 HET MSE B 119 8 HET MSE B 166 8 HET MSE B 185 8 HET MSE B 186 8 HET MSE B 225 8 HET MSE B 231 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 18(C5 H11 N O2 SE) FORMUL 3 HOH *61(H2 O1) HELIX 1 1 GLU A 75 LEU A 78 5 4 HELIX 2 2 ASP A 79 ASN A 95 1 17 HELIX 3 3 GLN A 110 LEU A 139 1 30 HELIX 4 4 SER A 145 ARG A 154 1 10 HELIX 5 5 SER A 167 MSE A 186 1 20 HELIX 6 6 LEU A 191 GLY A 193 5 3 HELIX 7 7 GLN A 194 ASN A 212 1 19 HELIX 8 8 ASN A 213 ASN A 218 1 6 HELIX 9 9 SER A 220 ALA A 240 1 21 HELIX 10 10 GLU B 75 LEU B 78 5 4 HELIX 11 11 ASP B 79 GLN B 94 1 16 HELIX 12 12 GLN B 110 HIS B 127 1 18 HELIX 13 13 HIS B 127 ALA B 140 1 14 HELIX 14 14 SER B 145 ARG B 154 1 10 HELIX 15 15 SER B 167 GLU B 187 1 21 HELIX 16 16 GLU B 190 GLY B 193 5 4 HELIX 17 17 GLN B 194 ASN B 218 1 25 HELIX 18 18 SER B 220 GLU B 241 1 22 LINK C GLY A 96 N MSE A 97 1555 1555 1.33 LINK C MSE A 97 N GLU A 98 1555 1555 1.33 LINK C GLU A 114 N MSE A 115 1555 1555 1.33 LINK C MSE A 115 N MSE A 116 1555 1555 1.33 LINK C MSE A 116 N ARG A 117 1555 1555 1.33 LINK C VAL A 118 N MSE A 119 1555 1555 1.33 LINK C MSE A 119 N GLY A 120 1555 1555 1.33 LINK C PRO A 165 N MSE A 166 1555 1555 1.33 LINK C MSE A 166 N SER A 167 1555 1555 1.33 LINK C LYS A 184 N MSE A 185 1555 1555 1.33 LINK C MSE A 185 N MSE A 186 1555 1555 1.33 LINK C MSE A 186 N GLU A 187 1555 1555 1.33 LINK C PHE A 224 N MSE A 225 1555 1555 1.33 LINK C MSE A 225 N THR A 226 1555 1555 1.33 LINK C GLN A 230 N MSE A 231 1555 1555 1.33 LINK C MSE A 231 N LYS A 232 1555 1555 1.33 LINK C GLY B 96 N MSE B 97 1555 1555 1.33 LINK C MSE B 97 N GLU B 98 1555 1555 1.33 LINK C GLU B 114 N MSE B 115 1555 1555 1.33 LINK C MSE B 115 N MSE B 116 1555 1555 1.34 LINK C MSE B 116 N ARG B 117 1555 1555 1.33 LINK C VAL B 118 N MSE B 119 1555 1555 1.33 LINK C MSE B 119 N GLY B 120 1555 1555 1.33 LINK C PRO B 165 N MSE B 166 1555 1555 1.32 LINK C MSE B 166 N SER B 167 1555 1555 1.33 LINK C LYS B 184 N MSE B 185 1555 1555 1.33 LINK C MSE B 185 N MSE B 186 1555 1555 1.33 LINK C MSE B 186 N GLU B 187 1555 1555 1.33 LINK C PHE B 224 N MSE B 225 1555 1555 1.33 LINK C MSE B 225 N THR B 226 1555 1555 1.33 LINK C GLN B 230 N MSE B 231 1555 1555 1.33 LINK C MSE B 231 N LYS B 232 1555 1555 1.33 CISPEP 1 SER B 164 PRO B 165 0 -0.11 CRYST1 46.790 92.050 47.640 90.00 99.78 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021372 0.000000 0.003684 0.00000 SCALE2 0.000000 0.010864 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021300 0.00000